Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by Phillip Capital and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 5
Author: Phillip Capital

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1219.3000 -5.40 (-0.44%)

NSE May 22, 2025 14:05 PM

Volume: 1.6M

Dr. Reddy's Laboratories Ltd.

10 Feb 2016

1219.30

-0.44%

Drreddy 10Feb2016

Buy: Dr. Reddy's Laboratories Ltd.

Recommendation Target

Phillip Capital

DRRD expects more drug launches in the US in FY17 than in FY16 as it visualises few datespecificandlitigationbasedopportunities. 9 DRRDtradesatanattractivevaluationof19x/15xFY17/18EPS,andwebelievemajority...

KRChoksey increased Accumulate price target of Dr. Reddy's Laboratories Ltd. to 1324.0 on 13 May, 2025.